Better Buy to Beat the TSX: Canada Goose Holdings Inc. or MedReleaf Corp.?

Canada Goose Holdings Inc. (TSX:GOOS)(NYSE:GOOS) and MedReleaf Corp. (TSX:LEAF) have throttled the TSX since being listed in 2017.

| More on:
The Motley Fool

The S&P/TSX Composite Index rose 11 points on April 12. The index has dropped 5.8% in 2018 thus far. The TSX was one of the worst-performing global exchanges in the first quarter. It has been a frustrating start to the year for the Canadian investor, and industry leaders are now warning that Canada is suffering from a bout of capital flight in the aftermath of United States tax reform.

Trade tensions and the threat of rising interest rates are enough to keep analysts anxious looking ahead. However, there are still attractive plays on the TSX and stocks could receive a boost if NAFTA negotiations move towards a new agreement in the near term, as is expected. Let’s look at two stocks today that have suffered from volatility since late January. Which should you buy?

Canada Goose Holdings Inc. (TSX:GOOS)(NYSE:GOOS)

Canada Goose is a Toronto-based outerwear designer, manufacturer, and retailer. Shares of Canada Goose have climbed 9.9% in 2018 as of close on April 12. However, since rebounding from a sharp drop after its fiscal 2018 Q3 results, Canada Goose stock has failed to reach its previous highs. Can it still offer the kind of explosive growth we saw in the second half of 2017?

Canada Goose released its fiscal 2018 third-quarter results on February 8. Revenue rose 27.2% year over year to $265.8 million, and adjusted EBITDA climbed 43.2% to $94.7 million. Wholesale revenue actually declined year over year, but growth was driven by remarkable numbers in direct-to-consumer revenue. The company opened seven new e-commerce sites, and revenue rose to $131.6 million compared to $72 million in the prior year.

Shares dropped in spite of these impressive earnings after the company failed to produce an annual outlook, and CEO Dani Reiss initially said the company did not plan to ramp up production in response to dwindling supply. However, in March, Canada Goose announced that it plans more in-house production in order to meet demand and increase profit going forward. The stock is up 3% month over month.

MedReleaf Corp. (TSX:LEAF)

MedReleaf is a Markham-based cannabis producer. Shares of MedReleaf rose 9.88% on April 12, but the stock has plunged 13% in 2018 so far, as cannabis stocks have been battered. MedReleaf released its fiscal 2018 third-quarter results on February 13.

Total sales rose to $11.3 million compared to $10.4 million, and gross profit increased to $9.98 million in comparison to $9.71 million in the prior year. Total grams sold were over 1.2 million compared to 993,259 in Q3 fiscal 2017. It was also a busy quarter, as MedReleaf signed an agreement to become a medical cannabis supplier for Shoppers Drug Mart and was granted a licence for the cultivation and production of medical cannabis from the Australian government.

Which stock should you buy today?

Canada Goose is entering its slow season, but its decision to ramp up production is promising. MedReleaf stock is up 15.4% week over week, and the cannabis market appears to be stabilizing after top producers have suffered steep corrections. At its current valuation, MedReleaf represents one of the best deals in the sector, and I like it to outperform Canada Goose from here on out.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned.

More on Investing

CI Financial goes private
Bank Stocks

CI Financial Wants to Go Private: What Investors Need to Know

Will the deal actually go through, or might it face government scrutiny?

Read more »

Canadian dollars are printed
Dividend Stocks

Transform Your TFSA Into a Cash-Generating Machine With Just $28,000

Canadians can turn their TFSAs into a cash-generating machine with money equivalent to four years’ contribution limits.

Read more »

Investor wonders if it's safe to buy stocks now
Tech Stocks

Balancing the Risks and Rewards of Investing in AI Stocks

Choosing a safe AI stock can be challenging if you need help understanding the underlying technology, business model, and, by…

Read more »

A Canada Pension Plan Statement of Contributions with a 100 dollar banknote and dollar coins.
Retirement

Want the Maximum $1,346.60 CPP? Here’s the Income You Need

Most CPP users receive the average pension but have ways to boost their retirement income.

Read more »

open vault at bank
Bank Stocks

RBC vs. TD: Which Canadian Bank Stock Is the Better Buy?

Let's dive into whether Toronto-Dominion Bank (TSX:TD) or Royal Bank of Canada (TSX:RY) are the best picks in the banking…

Read more »

stock research, analyze data
Stocks for Beginners

Prediction: 2 Top Stock Picks to Beat the Market For Years to Come

Are you wondering what Canadian stocks could deliver predictable long-term returns? These two stocks are worth a bet for the…

Read more »

Silver coins fall into a piggy bank.
Dividend Stocks

Here’s the Average RRSP Balance at 45 in Canada

The RRSP is a strong tool for investors, but only if you invest in top stocks like this ETF for…

Read more »

Start line on the highway
Dividend Stocks

Retirement Planning: Dividends vs. Growth (Or How About Both?)

Building a healthy mix of income and growth potential in your retirement portfolio is essential. Even if you can't access…

Read more »